Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Real-World Evidence Study of the Temporal Evolution in Treatment Patterns and Outcomes for Chronic Lymphocytic Leukemia

Winson Y. Cheung, Devon J. Boyne, Tamer N. Jarada, Chantelle Carbonell, Carolyn Owen

Blood (2023) 142 (Supplement 1): 7380.

https://doi.org/10.1182/blood-2023-178879

Published: 2023

Journal Articles

External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada

Carolyn Owen, Neil Chua, Devon Boyne, Ofodile Joe-Uzuegbu, Huma Shakir, Priyanka Gonga, Darren Brenner, Julia Elia-Pacitti, Emmanuel Ewara, Winson Y Cheung

Blood (2022) 140 (Supplement 1): 8024–8025.

https://doi.org/10.1182/blood-2022-160340

Published: 2022

Journal Articles

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

Andrew J. Cowan, MD, Shasank R Chennupati, PharmD, MPH, Yuan Xu, PhD, Ang Li, MDMS, David A. Garcia, MD, Edward Libby, MD, Catherine Fedorenko, MMSci, Scott D Ramsey, MD PhD, Veena Shankaran, MD, Winson Y Cheung, MDMPH

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141088

Published: 2020

Journal Articles

Intensity of End of Life Care for Hematologic Malignancy Patients in Western Washington, United States and Alberta, Canada

Ali Raza Khaki, MD, Yuan Xu, PhD, Shasank R Chennupati, PharmD, MPH, Scott D Ramsey, MD PhD, Catherine Fedorenko, MMSci, Veena Shankaran, MD, Andrew J. Cowan, MD, Winson Y Cheung, MDMPH

Blood (2020) 136 (Supplement 1): 21.

https://doi.org/10.1182/blood-2020-134825

Published: 2020

Journal Articles

Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone +/- Rituximab (CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)

Tom Kouroukis, MD, Winson Y. Cheung, Nizar Abdel-Samad, Sandeep Sehdev, Melanie Poulin-Costello, Brad Gillesby, Ewan J.D. Robson

Blood (2016) 128 (22): 3038.

https://doi.org/10.1182/blood.V128.22.3038.3038

Published: 2016

NARROW

A Real-World Evidence Study of the Temporal Evolution in Treatment Patterns and Outcomes for Chronic Lymphocytic Leukemia

External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

Intensity of End of Life Care for Hematologic Malignancy Patients in Western Washington, United States and Alberta, Canada

Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone +/- Rituximab (CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)

Email alerts

ASH Publications

American Society of Hematology

A Real-World Evidence Study of the Temporal Evolution in Treatment Patterns and Outcomes for Chronic Lymphocytic Leukemia

External Validation of the FLIPI Risk Score Measured at Initial Diagnosis and POD24 Among Previously Treated Individuals with Progressed Follicular Lymphoma in Alberta, Canada

Comparison of Outcomes and Utilization of Therapy in Multiple Myeloma Patients in the USA and Alberta, Canada

Intensity of End of Life Care for Hematologic Malignancy Patients in Western Washington, United States and Alberta, Canada

Granulocyte Colony-Stimulating Factor (GCSF) Use with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone +/- Rituximab (CHOP±R) Treatment for Aggressive Non-Hodgkin's Lymphoma (aNHL)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only